Trials / Completed
CompletedNCT03079648
Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride
A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
This study was conducted to investigate the effects of daily supplementation of Angelica gigas N. extract on improvement of Blood Triglyceride.
Detailed description
This study was a 12 weeks, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Angelica gigas N. extract or a placebo group. Fasting triglyceride profiles before and after the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Angelica gigas N. extract | capsules (2cap/d, 1,000mg/d) for 12 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Placebo for 12 weeks |
Timeline
- Start date
- 2017-03-02
- Primary completion
- 2018-04-06
- Completion
- 2018-04-06
- First posted
- 2017-03-14
- Last updated
- 2019-12-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03079648. Inclusion in this directory is not an endorsement.